Answers are grounded in this paper and cite their sources.
Case report demonstrates medical management of monostotic fibrous dysplasia in children, indicating that zoledronic acid can reduce bone pain and symptoms.
Fibrous dysplasia (FD) is an uncommon genetic disorder in which bone is replaced by immature bony and fibrous tissue, manifesting as slow-growing lesions. The craniofacial area is the most common site of fibrous dysplasia, and 9 out of 10 patients with fibrous dysplasia affecting the craniofacial bones present before the age of 5. This case of monostotic fibrous dysplasia of the mandible in a 06 year old child presented with severe bone pain and trismus. This case report emphasises on medical management of fibrous dysplasia with intravenous zoledronic acid resulting in prompt resolution of sign and symptoms.
No takes yet. Share an insight, caveat, or question.
Tomar et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: